Mitigating Human Error and Supporting Compliance with Smart Technology

Publication
Article
BioPharm InternationalBioPharm International Quality and Regulatory Sourcebook 2023
Volume 2023 eBook
Issue 1
Pages: 10–13

Technological advances hold promise for mitigating human error in the pharmaceutical industry, especially in quality assurance/quality control, by reducing the incidence of, and risk associated with, mistakes.

Standard quality control. Certification. Business, technology, internet and networking concept | Image Credit: © PHOTON_PHOTO - STOCK.ADOBE.COM

PHOTON_PHOTO - STOCK.ADOBE.COM

Facing new global challenges, pharmaceutical company leaders are looking to prioritize operational strategies to remain competitive in this rapidly evolving business environment. Recent events that range from the COVID-19 pandemic to new regulatory guidelines to economic inflation have required pharma manufacturers to find new ways to streamline workflows and minimize risks. Disruptions caused by the pandemic and related restrictions continue to impact supply chains and logistics worldwide. Additionally, many companies have shifted toward remote and hybrid working, and have increased their use of digital technologies to maintain business continuity and protect the health of employees.

These changes are accelerating the need for new innovations. One solution is the use of intelligent informatics in the pharmaceutical quality control (QC) laboratory to improve the quality and safety of drugs and reduce the risk of costly errors and recalls. However, while technology can simplify many workflows, it also comes with a learning curve and new burdens may be placed on its users. Pharma companies must determine the effectiveness of technological advancements and the potential challenges they may introduce in an environment like pharmaceutical quality assurance/quality control (QA/QC).

Read this article in BioPharm International’s March 2023 Quality and Regulatory Sourcebook eBook.

About the author

Mike Wilson, QA/QC Strategy, Waters Corporation

Article details

BioPharm International
eBook: Quality and Regulatory Sourcebook
March 2023
Pages: 10–13

Citation

When referring to this article, please cite it as Wilson, M. Mitigating Human Error and Supporting Compliance with Smart Technology. BioPharm International’s Quality and Regulatory Sourcebook eBook (March 2023).

Articles in this issue
Standard quality control. Certification. Business, technology, internet and networking concept | Image Credit: © PHOTON_PHOTO - STOCK.ADOBE.COM
Mitigating Human Error and Supporting Compliance with Smart Technology
Murrstock - Stock.adobe.com
Phase-appropriate Analytical Methodology
Business process management, Businessman plan a project with wooden cubes with icon business strategy on blue background. copy space. Image Credit: ©Worawut -Worawut - Stock.adobe.com
Evolution of Analytical Procedure Validation Concepts: Part II
Pharmacovigilance Automation
Pharmacovigilance Automation
Hand holding wooden block with tick mark, satisfaction survey ,mental health assessment, checklist business, project tracking, goal tracker, task completion concept. Image Credit: ©sewcream - sewcream-stock.adobe.com
Evolution of Analytical Procedure Validation Concepts: Part I
relif - Stock.adobe.com
Points to Consider for Knowledge Management Acceleration
Recent Videos
Christa Myers, CRB Group; Nadiyra Walker Speight, Fujifilm Diosynth Biotechnologies
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Gives Recommendations Including Several Orphan Drugs for Approval in December

Susan Haigney
December 17th 2024
Article

EMA's committee gave recommendations for marketing authorization of 17 drugs in December, which include therapies for rare heart conditions, anemia, and liver disease.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk to Acquire Manufacturing Sites Upon Catalent Acquisition and Acquires Novavax’s Czech Republic Site

Feliza Mirasol
December 10th 2024
Article

The European Commission’s approval of the Catalent acquisition by Novo Holdings includes the related acquisition of three manufacturing sites by Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

Shining Pro - Stock.Adobe.com

Enhancing Quality Through Training

Susan Haigney
December 7th 2024
Article

With so many personnel involved in the development and manufacture of pharmaceuticals, proper training of all staff is key to ensuring a quality product.

Growing Bacteria in Petri Dishes on agar gel Scientific experiment. | Image Credit: ©luchschenF- Stock.Adobe.com

Overcoming Viral Clearance Challenges

Cynthia A. Challener
December 5th 2024
Article

Many factors must be considered to overcome the challenges associated with viral clearance.

3d rendering. Empty blank black metal sphere balance scale on white background. | Image Credit: ©PATARA – stock.adobe.com

Comparability in Accelerated or Stressed Stability Studies Using a Quality Range

Richard K. Burdick
December 4th 2024
Article

A statistical procedure based on a quality range is proposed for demonstrating comparability between pre-change and post-change process slopes in an accelerated or stressed stability study.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

New Drug Shortages Monitoring Platform in Europe

Susan Haigney
December 4th 2024
Article

A new platform allowing market authorization holders to report drug shortages has gone live.

© 2024 MJH Life Sciences

All rights reserved.